Clinical Trial

Plasma Biomarker in Amblyopia Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 31, 2023 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This prospective study aims to observe the predictive effect of peripheral blood plasma biomarker on the outcome of treatment in children with different types of amblyopia. We also investigated the mechanism of neuromodulation in the visual development of amblyopic children.
Trial Details
NCT Number NCT05705778
Lead Sponsor Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions Amblyopia
Enrollment 600 participants
Start Date 2022-11-01
Primary Completion 2025-10-31 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2023-01-31